![Michael DiVecchia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael DiVecchia
Geschäftsführer bei Elicio Therapeutics, Inc. (Old)
Aktive Positionen von Michael DiVecchia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Geschäftsführer | - | - |
Karriereverlauf von Michael DiVecchia
Ehemalige bekannte Positionen von Michael DiVecchia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Geschäftsführer | 01.02.2022 | 01.01.2024 |
Personalreferent | 01.02.2022 | 01.01.2024 |
Ausbildung von Michael DiVecchia
Syracuse University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Human Resources Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELICIO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Michael DiVecchia
- Erfahrung